Skip to main content
Download PDF

Factors influencing medication adherence among patients with severe mental disorders from the perspective of mental health professionals

BMC Psychiatry volume 22, Article number: 22 (2022) Cite this article

Abstract

Background

Medication adherence is a common issue influenced by various factors among patients with severe mental disorders worldwide. However, most literature to date has been primarily quantitative and has focused on medication adherence issue from the perspective of patients or their caregivers. Moreover, research focused on medication adherence issue in China is scarce. Present study aims to explore the influential factors of medication adherence among patients with severe mental disorders form the perspective of mental health professionals in Hunan Province, China.

Methods

A qualitative study was performed in Hunan Province, China with 31 mental health professionals recruited from October to November 2017. And semi-structured interviews or focus group interviews were conducted along with audio recordings of all interviews. Interview transcripts were then coded and analyzed in Nvivo software with standard qualitative approaches.

Results

Three major themes influencing medication adherence among patients with severe mental disorders were identified as: (1) attitudes towards mental disorder/treatment; (2) inadequate aftercare; (3) resource shortages.

Conclusions

This qualitative study identified the factors influencing medication adherence among patients with severe mental disorders in China. As a locally driven research study, it provides practical advice on medication adherence promotion for mental health workers and suggests culturally tailored models that improve the management of patients with severe mental disorders in order to reduce economic burden on individual and societal level.

Peer Review reports

Background

Medication adherence is defined as a patient’s medication taking behavior that complies with recommendations from healthcare providers [1]. To maintain treatment effectiveness and prevent relapse, it is important for patients with severe mental disorders, such as schizophrenia, bipolar disorder and major depressive disorder, to keep taking their medications continuously over the long term [2,3,4]. However, the rates of medication nonadherence among schizophrenia patients, bipolar disorder patients and patients with major depressive disorder in China were approximately 56, 48 and 51% at the beginning of 21st century, respectively [5,6,7,8]. As a result of this poor adherence, 60% of patients with severe mental disorders have experienced high rates of disability, rehospitalization and suicide [9, 10], which has increased the burden on the healthcare system [11]. Therefore, it is worthwhile to carefully examine the issue of medication adherence, which plays a key role in the management and improvement of clinical outcome in patients with severe mental disorders.

Medication adherence among patients with severe mental disorders is a complex issue determined by a multitude of factors, such as treatment effect, patient insight, attitudes toward medication, financial and emotional support from family members, income situation, side effects, cultural context, level of therapeutic alliance with therapists, and aftercare environment after discharge [12,13,14,15,16,17,18]. With respect to China, a shortage in the mental health workforce has also been observed by Xiang et al. [19] , which may contribute to medication nonadherence [14]. Moreover, according to the World Health Organization (WHO)’s report in 2018 [20], a lack of mental health resources, including mental health facilities, government expenditure on mental health, and the mental health workforce, is a prominent issue worldwide that negatively impacts rates of medication adherence. Although researchers have used various methodologies to study medication adherence in patients with severe mental disorders, most studies to date have focused on the perspectives of patients or their caregivers (usually their family members) [21,22,23,24]. The limitation of these papers lies in the potential omission of the opinion from other important parties in the process of care, who may also provide insights into our understanding of the issue. Mental health professionals such as psychiatrists, psychiatric nurses, psychologists, and social workers are all valuable sources to seek opinions from, as they are experienced in handling adherence issues and are also knowledgeable in identifying other contributing factors on the pharmaceutical, psychosocial, and systemic level. However, to the best of our knowledge, only two qualitative studies had focused on mental health professionals’ attitudes towards medication adherence, with one conducted in rural China [25] and the other conducted in 4 European countries (England, Germany, Italy and the Netherlands) [26]. Thus, qualitative research that explore their perspectives on medicine adherence is key to tackling this issue comprehensively.

China, one of the world’s most rapidly developing countries, also faces a serious mental health burden, of which severe mental disorders [27] constitute a significant part. In China, lifetime prevalence of schizophrenia, bipolar disorder and major depressive disorder have reached 0.7, 0.6 and 3.4%, respectively [28]. A meta-analysis, however, reported that the treatment rate of schizophrenia in psychiatric institutions was only 31% [29]. It implies that nearly 70% of schizophrenia patients did not receive treatment. The disability-adjusted life-year (DALYs) rate per 100,000 of schizophrenia and bipolar disorder are 322.8 and 109.3 respectively [27]. Considering factors such as disparities in mental health services, mental health workforce scarcity, and weaknesses in community-based management, medication adherence is a key factor that determines performance in managing severe mental disorders as well as an important indicator of the overall quality of care. To the best of our knowledge, qualitative research focused on the medication adherence situation in China is insufficient. Using a qualitative approach with semi-structured interviews and focus groups, this study explores influential factors of medication adherence in Hunan, China, with a particular focus on the perspective of mental health professionals from urban and rural areas. The study may also provide useful information for improving the management of severe mental disorders.

Methods

Participants

Participants were enrolled by mental health professionals in mental health institutions from October to November 2017 and included psychiatrists based in mental health hospitals, directors of psychosocial rehabilitation services (also called clubhouses), researchers of public mental health, social workers, and psychological counselors. According to previous studies [26, 30], we defined that all participants should have at least 2 years working experience related to mental health. We conducted in-depth semi-structured interviews and focus groups, and performed participant observation as well. After the first interview, we identified the next participant(s) by means of the snowball sampling method [31]. The number of participants enrolled was based on data saturation, that is, data collection was terminated once no new themes were identified and a theoretical end point of saturation was reached [32, 33]. Ultimately, a total of 31 participants were recruited: 14 psychiatrists, 2 researchers of public mental health, 7 directors of clubhouses, 7 psychological counselors, and 1 social worker were included. In addition, we conducted 22 individual interviews as well as 2 focus groups (including 3 psychiatrists and 6 psychological counselors). Detailed demographic information of participants is displayed in Table 1. All participants were subsequently numbered during the process of data analysis to aid in organization and analysis.

Table 1 Respondent information
Full size table

Data collection

One researcher conducted all interviews in Mandarin and each interview averaged 45-60 minutes. Observational field notes were collected as well. In addition, all interviews were audio-recorded and were conducted with a list of pre-determined open-ended questions (Table 2). The audio records of all interviews were transcribed verbatim in Mandarin by other researchers unfamiliar with this study. All of the participants signed informed consent before the interview. The study was approved by the ethics committee of the Second Xiangya Hospital of Central South University.

Table 2 Interview guide
Full size table

Data analysis

Coding was performed using NVivo software (version 11). To minimize bias, each of the two coders coded the two interviews independently and differences were discussed to determine the initial coding framework. Coding and thematic analysis of remaining interviews was then conducted by one researcher. To increase the validity of the study, themes and subthemes were reviewed and verified by other researchers. Finally, researchers translated themes, subthemes and representative quotations into English. In addition, quotations were edited to correct grammar or remove content of repeated words and stutters.

Results

We extracted three themes that were likely related to the challenges of medication adherence in patients with severe mental disorders: 1) attitudes towards mental disorders/treatment; 2) inadequate aftercare; and 3) resource shortages. The themes and subthemes were visualized in Table 3.

Table 3 Themes and subthemes about challenges of medication adherence in patients with severe mental disorders
Full size table

Attitudes towards mental disorders/treatment

Inadequate knowledge about mental disorders and treatment

Mental health professionals stated that some patients or their families did not hold a correct or scientific understanding of mental disorders and treatment. As a result, patients or their families thought that medication could be discontinued once the symptoms disappeared after a period of treatment. Additionally, some of these patients might only continue treatments such as Chinese traditional medicine or psychotherapy. Moreover, some patients or families from rural areas believed in supernatural etiologies of mental disorders, which led them to embrace alternative methods that were considered as more effective cures.

“Some members (patients) thought that they do not need to take medicine, they are normal. ... They think I don’t need to take medicine anymore, I’m alright. They definitely think that not taking medicine is normal and good. Many of them expressed that I don’t need to take medicine tomorrow, I will be fine. I can do whatever I want.” (#19, directors of clubhouse)

“Some patients’ families thought that their children were different from other children. They think that previously their children (patients) were stressed, and if they could pay more attention to their children, then they could try to see if it can be effective without taking medicine. (#2, psychiatrist)

“Some patients’ families were reluctant to accept that their children (patients) had a mental illness. I saw a patient with severe psychotic symptoms … and suggested his family to take him to hospital. But they thought that their kid was healthy and just possessed by a ghost. They thought he would get better if they used some ritual methods.” (#25, psychological counselor)

Insight

Insight means that the patient’s understanding of their symptoms, illness, prognosis and treatment aligns with that of their healthcare professionals [34]. In general, patients with good insight might be more likely to be compliant with their mental health providers’ plan and maintain medication treatment as prescribed.

Some patients with severe mental disorders, however, had poor insight into their conditions. This lack of awareness probably led many of them to resist medication treatment.

“We use medication to treat patients. For example, schizophrenia patients with delusions and abnormal behaviors might refuse to accept that they had mental disorder. But, after antipsychotic treatment, they might realize their own mental health problems, be more willing to take antipsychotics, … and finally return to their daily life.” (#1, psychiatrist)

“First of all, it is necessary to control their (patients) symptoms, … the drug compliance is better, and the side effects are lighter, so that they might maintain medication treatment more readily.” (#15, researcher of public mental health)

Side effects of treatment

It concerned some patients or their families that medications had side effects that might influence everyday life. For example, some patients might become overweight, or present with an even more severe metabolic syndrome, and other patients might feel drowsy and indolent the whole day which led them to believe that medication was harmful for them. Obviously, they worried about the side effects of medication and neglected to appreciate the drugs’ effectiveness.

“Some of them (patients) might discontinue medication because it made them fat. … However, most of them relapsed after they discontinue their medication treatment.” (#25, psychological counselor)

“Without supervision of parents, some students (patients) might discontinue medication because of side effects, then the symptoms might relapse.” (#30, psychological counselor)

Stigma

Carrying the fear that other people might know about their diagnosis of a mental health disorder, some patients refused to continue taking medication in a public space. For a similar reason, some of the patients or their families would rather receive treatment from internal medicine outpatient departments in general hospitals than outpatient departments of psychiatry in general hospitals or mental hospitals. Therefore, stigma about mental disorders might constrain the use of available mental health resources and might eventually affect the level of medication adherence.

“There are many reasons that patients with severe mental disorders may be reluctant to take medication, such as stigma, severe side effects or poor insight.” (#15, researcher of public mental health)

“We can find certain forms of social discrimination of mental disorders, … some patients’ families thought it might be disgraceful to send patients to a mental health hospital, so they might procrastinate treatment for couple years, ten years, or even a couple decades.” (#10, psychiatrist)

Inadequate aftercare

Aftercare from families

Almost all patients with severe mental disorders discharged from hospital were taken care of by their families at home. Therefore, the burden of rehabilitation was primarily born by patients’ families. In fact, most of the families needed to supervise the patients to ensure they take medication every day. Sometimes, families even needed to deceive patients into taking medication, although some of the them failed at this.

“From our point of view, due to traditional notions or conventions, … it is patients’ families that have been faced with the heaviest burden in supporting this kind of (rehabilitation) work. … Therefore, the role and values of patients’ families in managing medication adherence in severe mental disorders cannot be underestimated.” (#6, psychiatrist)

“Generally, due to the close relationship among family members in traditional Chinese culture, we will tell patients’ families that patients’ recovery requires a certain period of supervised care and that the medication treatment needs to be continued. And we will also write down some important points, such as when to make a follow-up visit and what kind of medical examination needs to be completed at the next visit, noted on patients’ outpatient medical record book. Lastly, we will tell patients’ families to keep the medication in a secure location.” (#2, psychiatrist)

Aftercare from community

Aftercare from community mostly referred to rehabilitation clubhouses and the 686 Project in this study. In 2004, the 686 Project was initiated to provide comprehensive mental health services to patients with severe mental disorders [35, 36]. This project aimed to improve medication adherence in patients with severe mental disorders by providing free medication routinely and conveniently. Members of clubhouses were patients with severe mental disorders. Referring to patients as members in the clubhouse could reduce stigma and be helpful in creating an appropriate atmosphere for the rehabilitation of patients. The clubhouse staff would ask members everyday if they have taken their medication. And members would discuss with each other the results and practice of taking medication. Additionally, lectures on medication adherence were provided from time to time to create a virtuous cycle for better recovery.

“In the clubhouse, members would discuss together, … they would often ask other members’ views about medication. … The result of our survey last time showed that 90% of our members continued medication treatment. However, probably 50% of patients or even lower continued medication treatment out in the community. Good medication adherence might be helpful to reduce the relapse rate for patients. … The environment in the clubhouse could help members keep a stable state.” (#17, directors of clubhouse)

“For one thing, members will be optimistic (in the clubhouse). For another, members will realize the importance of medication adherence and hold a global perspective about mental disorders as well as medication adherence.” (#18, directors of clubhouse)

“They provide them (patients with severe mental disorders) medication for free in community. This is the 686 Project.” (#1, psychiatrist)

Resource shortages

Financial resources

Some patients might discontinue treatment due to the financial burden. For example, most patients and their families from rural areas or county-level areas would seek out the top hospitals in urban areas in order to pursue better treatment, which might cost them a great expense for transportation and accommodation. Even if the expense of hospitalization could be covered by their healthcare insurance, policies often limited the coverage rate of non-local patients mentioned above. Additionally, expenses incurred in the outpatient department, based on a related policy, were likewise not included in the healthcare insurance plan. Therefore, patients might need to use more expensive medications with more side effects.

“Although huge amounts of patients come to our outpatient department for treatment, the expense is not entirely covered by healthcare insurance. … Without the subsidy of healthcare insurance, they may take on too great of a financial burden. This is because most of them (patients with severe mental disorders) have no job and they depend on their families to support them financially. Some of them have to travel a great distance to come here, and it costs them many fees for transportation and accommodation, which is even more expensive than the medical expenses.” (#7, psychiatrist)

“Some patients (from rural or county-level areas) relapsed many times due to lots of reasons. First of all, previous treatment of this illness already caused them to spend so much money, which made future treatment seem even more unaffordable. … In other words, they were just lacking money (for treatment).” (#10, psychiatrist)

Mental health workforce

Several interviewees mentioned that supervision and education of medication adherence required a professional workforce. However, due to limited mental health workforce in the community mental health system and a large flow of patients in outpatient departments in recent years, psychiatrists were often too busy to explain or promote medication adherence to patients in outpatient departments. In addition, it remains difficult to establish a relatively mature system of supervision for mental health management, especially to address medication adherence.

“There are not enough psychiatrists in our country. During patients’ early stages of severe mental disorders, there needs to be a large related workforce to manage patients when their symptoms are stable and to check if they take medication regularly. All of this labor requires a relatively large mental health workforce to support it. … If there are social workers, and an adequate mental health workforce in this field, they can supervise the symptoms and the treatment of patients. … However, there is a shortage in our country.” (#5, psychiatrist)

Social resources

Social resources, especially from government sources, are likely to improve psychiatric patients’ medication adherence. Currently, the management of patients with mental disorders, especially those in the community, is underdeveloped. However, the government did implement some measures, such as the 686 Project, a series of mental health policies and various mental health services designed to meet the needs of psychiatric patients in the community.

“In our country, most mental health professionals only focus on the management of patients in mental health hospitals. This may require the government to implement measures allowing psychiatrists to go to communities and to treat patients there. And it has been promoting such measures. For example, psychiatrists, nurses and other related mental health professionals may organize a team, then go to communities and distribute medications to patients with severe mental disorders. This is the 686 Project which is in process.” (#1, psychiatrist)

“The most important thing is that they (patients with severe mental disorders) need social support. … It is a tough issue that has caused some of them to relapse many times. Therefore, in order to see more positive results in medication adherence, the government needs to actively intervene and our society needs to adopt some measures.” (#10, psychiatrist)

Discussion

In our study, we identified that attitudes towards mental disorders/treatment, inadequate aftercare environment, and resource shortages might affect medication adherence in patients with severe mental disorders in the Chinese context.

Attitudes towards mental disorders/treatment

Multiple studies have shown that psychiatric patients’ or their family members’ attitudes towards mental disorders and treatment can impact medication adherence to various degrees [16, 26, 37, 38]. Additionally, results of a cross-sectional study revealed that Asians held more negative beliefs towards taking medication compared to Europeans [39]. In our qualitative research, we found that knowledge about mental disorders and treatment, patients’ levels of insight, awareness of the side effects of the treatment, and social stigma could also influence psychiatric patients’ medication adherence.

In the Chinese context, patients or their family members’ inadequate knowledge about mental disorders may lead to misconceptions about the care received, which results in poor medication taking behaviors. Consistent with previous studies, we found inadequate knowledge about mental disorders and treatment being one of the risk factors of medication nonadherence [17, 18]. In China, a large number of patients with mental health disorders and their family members perceive that continuous psychotropic medication use can be harmful and addictive [16, 40]. Many of them sought help from traditional Chinese medicine or superstitious methods [29, 41]. Additionally, previous literature suggested that poor insight into mental disorders, concerns over the side effects of medications, and perceived stigma about mental disorders constrained proper adherence to medications [22, 25, 42]. First, patients with severe mental disorders who have poor insight into their conditions are less willing to continue medication or to follow their psychiatrist’s medication plan rigorously [25]. Second, psychotropic medications like antipsychotics or antidepressants may introduce certain side effects, such as drowsiness, weight gain, diabetes, or sexual dysfunction, which might impact patients’ daily functioning and directly decrease their medication adherence [43]. Last, as stigma toward patients with severe mental disorders is quite common in China [44, 45], Saxena et al. investigated that stigma towards mental disorders could constrain the use of available mental health resources [46]. Worried about being discriminated by others, many patients might avoid taking medications in public space or even discontinue their medications. Even their family members might also discourage them for the same reason [45, 47].

Several researchers concluded that collaborative decision making, also termed therapeutic alliance, enables patients with mental disorders to be more involved in choosing their medication regime, which is a key factor for better medication adherence [42, 48, 49]. A shared decision-making process could empower patients to actively communicate with their mental health providers and help providers be aware of the difficulties that a patient faces during treatment. As a result of this therapeutic collaboration, patients and their family members’ attitudes towards mental health and treatment would be more positive and their stigma could be reduced as well. Moreover, with better communication with their psychiatrists, patients might be more satisfied with their treatment and report fewer side effects due to timely management [22]. Noordraven et al. demonstrated that insight was less strongly associated with medication adherence than motivation for treatment, so it may be more important to improve motivation as the first step in patients with poor insight as the recovery of insight was difficult and time consuming [24]. In this case, psychoeducation could also be employed to spread the knowledge about mental disorders and treatment, enhance insight, and manage side effects, and reduce stigma, which may ultimately improve medication adherence [14, 26, 50,51,52,53].

Inadequate aftercare

Aftercare refers to mental health care given outside the hospital. It consists of supervision of medication use, follow-up of recurrence, rehabilitation of social function as well as work skills training. Due to the clinical characteristics of severe mental disorders (e.g., chronic course and impaired social function), aftercare is one of the key factors that determines the prognosis of severe mental disorders. In China, patients with mental disorders mostly live with or have close connection with their family members, so the burden of aftercare often falls on the latter. However, as their family members’ knowledge of and time dedicated to aftercare is often limited, the aftercare burden experienced by patients’ family members was inversely correlated with patients’ medication adherence, as shown in a previous study [54]. Another research study in China also demonstrated that patients with severe mental disorders heavily relied on the aftercare from their family members [55], which urged the spread and development of community-based mental health programs for patients and caregivers. As a large part of community-based mental health services still requires family participation [56], it is understood that aftercare from patients’ families and rehabilitation both play significant roles in maintaining medication adherence [14].

In China, the government has launched a program in 2004 called the 686 Project to improve community-based mental health services. The 686 Project was initiated to provide comprehensive monitoring, key mental health treatment, rehabilitation, and prevention services to patients with severe mental disorders from a wide range of urban and rural communities [35, 36, 57, 58]. Additionally, an increasing number of rehabilitation services have been emerging including the rehabilitation clubhouse model, farming programs, and workstation programs [50, 59, 60]. In this qualitative research, we mainly focused on the rehabilitation clubhouse as one of the community-based mental health services currently offered. Previous literature identified the positive influence of mental health rehabilitation services on prevention, treatment, and rehabilitation of mental disorders [50, 61]. Consistent with these studies, we found that mental health aftercare played an essential role in medication adherence in patients with severe mental disorders. However, the aftercare offered by patients’ family members and their communities is currently inadequate. Therefore, besides improving caregivers’ knowledge of mental health aftercare, multiple types of community-based mental health services or innovative service models are needed. For example, Xu et al. demonstrated that mobile text messaging was an effective way to integrate family-based aftercare into community-based aftercare, leading to improvements in medication adherence in patients with severe mental disorders [62].

Resource shortages

In the present study, we found that the shortage of financial resources, the mental health workforce, and social resources may be among the main factors that affected medication adherence in patients with severe mental disorders. In China, there are currently many challenging issues causing this resource shortages for mental health. For example, in considering financial resource shortages, the health insurance system in China has developed separate reimbursement models in urban and rural areas, which might increase inequity of mental health resources offered across different areas [63]. Even with health insurance coverage, many families cannot afford the expenses of treatment for severe mental disorders due to the chronicity of the disease. Therefore, some of them used less expensive medications with more side effects, which might increase the risk of medication nonadherence. Second, medication adherence in patients with severe mental disorders requires adequate supervision and education from mental health professionals. However, in 2015, there were 27,733 licensed psychiatrists (2.02 per 100,000 population) and 57,591 psychiatric nurses (4.19 per 100,000 population) in China [36]. In contrast, according to the mental health atlas of WHO in 2014 [64], there were 7 psychiatrists per 100,000 population and 24.1 psychiatric nurses per 100,000 population in European regions, while there were 0.1 psychiatrists per 100,000 population and 0.6 psychiatric nurses per 100,000 population in African regions. This stretched workforce may affect the medication adherence in patients with severe mental disorders and may limit the access for patients to seek help. The limited mental health workforce constitutes an important barrier to proper mental health service delivery, which in turn, slows down the process of services integration [65]. Finally, different levels of social resources were scarce or fragmented in distribution, including mental health policies, non-governmental organization support, mental health services (especially community-based services) and support from social networks. All of these may provide substantial support in the integration of mental health resources, spread of psychoeducation, case management and so on, which are vital to improve the medication adherence in patients with severe mental disorders. In a word, mental health resource scarcity may constrain the availability of mental health services and essential medication for patients, which eventually hinders the medication adherence in patients with severe mental disorders.

In the past two decades, the Chinese government implemented several effective interventions to strengthen and integrate mental health resources. First, the 686 Project, initiated in 2004, was a comprehensive service delivery model aiming to integrate hospital services, community case management, prevention and monitoring services, treatment, and rehabilitation services [36]. Second, as suggested by one of our previous studies, the rehabilitation clubhouse model has been in use in Hunan Province, China, and both the central and provincial governments took active steps to promote its development in more areas [50, 66]. Third, alongside strategies to improve undergraduate and graduate medical education [67], one of the most efficient steps taken to advance mental health workforce development was the psychiatrist licensing program announced by the National Family Planning and Health Commission in 2015 [68]. This program allows physicians who were already in practice to receive further training in psychiatry and to be licensed as psychiatrists. Finally, a series of mental health policies has been launched since 2000 [69], including the Mental Health Law of the People’s Republic of China was released on 2011 and came into effect from 2013 [19, 70, 71]. Although the government has initiated a series of steps to reinforce mental health resources, their uneven distribution still persists [72]. Furthermore, Thornicroft et al. demonstrated that a balanced approach in planning community-based and hospital-based mental health services was effective in both urban and rural areas [73]. By gradually strengthening community-based services, medication adherence is expected to improve in patients with severe mental disorders that often require more supervision and nearby assistance.

Adequate mental health resources are one of the foundations to improving medication adherence in patients with severe mental disorders. Due to the challenges of lacking mental health resources that China has confronted, it is vital to implement measures that are well adapted to the local context. First, the government should mobilize existing mental health resources, both to improve access to and increase the capacity of mental health services. Second, in order to reduce inequity and fragmentation of mental health resources between urban and rural areas, we can designate mental health professionals from urban areas to rural areas periodically as well as make use of telemedicine. For example, online consultation is considered efficient in balancing the distribution of mental health resources between urban and rural areas, and even between first-tier cities and second-tier cities. Third, to implement mental health policies efficiently from top to bottom, local-level execution and national-level promotion are equally important. Fourth, despite the heavy economic burden of mental disorders, equitable allocation of financial resources in mental health should still be emphasized, as it not only improves medication adherence in patients with severe mental disorders but also reduces the overall cost of mental health. Finally, non-psychiatric mental health professionals, including psychologists, counselors, social workers, and occupational therapists are also currently in high demand [68]. Diversifying the mental health workforce is therefore urgently needed to relieve psychiatrists’ and psychiatric nurses’ burden and provide comprehensive care.

Implications

The issue of medication nonadherence in patients with severe mental disorders has its own unique circumstances in different settings, and this qualitative study provided evidence based on the Chinese context to illuminate the effects of local conditions on clinical work. In clinical work, psychiatrists and nurses should pay more attention to the therapeutic alliance with patients and patients’ families, which can assist them in identifying patients’ insight and addressing the side effects of treatment in a timely manner to improve clinical outcomes. Moreover, psychiatrists and nurses should strengthen psychoeducation regarding mental disorders and treatment in patients and their families to reduce their misconceptions. Considering the importance of psychiatric community rehabilitation in medication adherence, governments should establish local community-based mental health services. As some mental health projects (e.g., 686 Project) and mental health policies have achieved certain improvement in medication adherence in some areas of China, governments should promote the successful and culturally adapted mental health models to other areas in China as well as integrate the mental health workforce at all levels to implement the mental health models efficiently. With the aforementioned effective steps, the future mental health system may improve the medication adherence in patients with severe mental disorders and reduce the economic burden for patients and society at large in China.

Limitation

One limitation of this qualitative study is that the sample size is relatively small. However, saturation did occur during the process of participant enrollment, which suggested the adequacy of the sample size in this particular study. In addition, there is potential bias caused by the snowballing sampling method which is a purposive sampling. Nevertheless, as purposive sampling is widely used in qualitative studies to identify and select information-rich participants related to the phenomenon of interest, snowballing sampling method is a highly-efficient way to identify potential participants from whom researchers may explore more useful information [31]. Another limitation is that the present study only looked at rehabilitation clubhouses and the 686 Project as examples of community-based mental health services, which may not reflect the whole picture nationally. The occurrence of data saturation in our case may be due to the location of our research, since the rehabilitation clubhouses and 686 Project were both in Hunan Province and more successful in promoting medication adherence than other forms of mental health aftercare in community settings. Along the same lines, in considering the provincial differences in mental health services across the country, the fact that our findings were entirely generated from Hunan province may limit the data applicability when generalized to the national level. But given that we have investigated medication adherence in patients with severe mental disorders in both urban areas and rural settings, it may still provide useful information to researchers in the field. Furthermore, it may also provide support for this kind of research in other Asian countries with a cultural context similar to that of China. However, as a qualitative study, there may be limited generalizability beyond our setting.

Conclusion

In summary, the present study focused on the perspectives of mental health professionals to identify factors influencing medication adherence among patients with severe mental health disorders in Hunan Province, China. Our findings provide practical advice for mental health providers on the promotion of medication adherence among patients with severe mental disorders. Moreover, this locally driven research also suggests culturally tailored models that improve the management of patients with severe mental disorders in order to reduce economic burden on individual and societal level. Future researchers could further explore the medication adherence among patients with severe mental disorders in other cultural contexts.

Availability of data and materials

The data generated and analyzed during the current study are not publicly available to protect the anonymity of the participants. Materials may be available from the corresponding author upon reasonable request.

Abbreviations

WHO:

World Health Organization

DALYs:

Disability-adjusted life-year

References

  1. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353(5):487–97.

    Article  CAS  PubMed  Google Scholar 

  2. Lehman AF, Lieberman JA, Dixon LB, McGlashan TH, Miller AL, Perkins DO, et al. Practice guideline for the treatment of patients with schizophrenia, second edition. Am J Psychiatry. 2004;161(2):1–56.

    PubMed  Google Scholar 

  3. Galletly CCD, Dark F, Humberstone V, Jablensky A, Killackey E, Kulkarni J, et al. Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the management of schizophrenia and related disorders. Aust Nz J Psychiatry. 2016;50(5):410–72.

    Article  Google Scholar 

  4. Practice guideline for the treatment of patients with major depressive disorder (revision). American Psychiatric Association. Am J Psychiatry. 2000;157(4 Suppl):1–45.

  5. Lacro JP, Dunn LB, Dolder CR, Leckband SG, Jeste DV. Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: a comprehensive review of recent literature. J Clin Psychiatry. 2002;63(10):892–909.

    Article  PubMed  Google Scholar 

  6. Sajatovic M, Valenstein M, Blow F, Ganoczy D, Ignacio R. Treatment adherence with lithium and anticonvulsant medications among patients with bipolar disorder. Psychiatr Serv. 2007;58(6):855–63.

    Article  PubMed  Google Scholar 

  7. Sajatovic M, Valenstein M, Blow FC, Ganoczy D, Ignacio RV. Treatment adherence with antipsychotic medications in bipolar disorder. Bipolar Disord. 2006;8(3):232–41.

    Article  CAS  PubMed  Google Scholar 

  8. Zhou Q, Wu ZG, Wang Y, Liu XH, Chen J, Wang Y, et al. Clinical characteristics associated with therapeutic nonadherence of the patients with major depressive disorder: A report on the National Survey on Symptomatology of Depression in China. CNS Neurosci Ther. 2019;25(2):215–22.

    Article  PubMed  Google Scholar 

  9. Weiden PJ, Kozma C, Grogg A, Locklear J. Partial compliance and risk of rehospitalization among California medicaid patients with schizophrenia. Psychiatr Serv. 2004;55(8):886–91.

    Article  PubMed  Google Scholar 

  10. Llorca PM. Partial compliance in schizophrenia and the impact on patient outcomes. Psychiatry Res. 2008;161(2):235–47.

    Article  PubMed  Google Scholar 

  11. Cutler DM, Everett W. Thinking outside the pillbox--medication adherence as a priority for health care reform. N Engl J Med. 2010;362(17):1553–5.

    Article  CAS  PubMed  Google Scholar 

  12. Novick D, Montgomery W, Treuer T, Aguado J, Kraemer S, Haro JM. Relationship of insight with medication adherence and the impact on outcomes in patients with schizophrenia and bipolar disorder: results from a 1-year European Outpatient Observational Study. Value Health. 2014;17(7):A455.

    Article  CAS  PubMed  Google Scholar 

  13. Gilmer TP, Dolder CR, Lacro JP, Folsom DP, Lindamer L, Garcia P, et al. Adherence to treatment with antipsychotic medication and health care costs among medicaid beneficiaries with schizophrenia. Am J Psychiatry. 2004;161(4):692–9.

    Article  PubMed  Google Scholar 

  14. Wang X, Zhang W, Ma N, Guan L, Law SF, Yu X, et al. Adherence to antipsychotic medication by community-based patients with schizophrenia in china: a cross-sectional study. Psychiatr Serv. 2016;67(4):431–7.

    Article  PubMed  Google Scholar 

  15. Carrick R, Mitchell A, Powell RA, Lloyd K. The quest for well-being: a qualitative study of the experience of taking antipsychotic medication. Psychol Psychother. 2004;77(Pt 1):19–33.

    Article  PubMed  Google Scholar 

  16. Ho SC, Jacob SA, Tangiisuran B. Barriers and facilitators of adherence to antidepressants among outpatients with major depressive disorder: a qualitative study. PLoS One. 2017;12(6):e0179290.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Sajatovic M, Levin J, Fuentes-Casiano E, Cassidy KA, Tatsuoka C, Jenkins JH. Illness experience and reasons for nonadherence among individuals with bipolar disorder who are poorly adherent with medication. Compr Psychiatry. 2011;52(3):280–7.

    Article  PubMed  Google Scholar 

  18. Vargas-Huicochea I, Huicochea L, Berlanga C, Fresan A. Taking or not taking medications: psychiatric treatment perceptions in patients diagnosed with bipolar disorder. J Clin Pharm Ther. 2014;39(6):673–9.

    Article  CAS  PubMed  Google Scholar 

  19. Xiang YT, Yu X, Sartorius N, Ungvari GS, Chiu HF. Mental health in China: challenges and progress. Lancet. 2012;380(9855):1715–6.

    Article  PubMed  Google Scholar 

  20. Organization GWH. Mental health atlas 2017; 2018.

    Google Scholar 

  21. Higashi K, Medic G, Littlewood KJ, Diez T, Granstrom O, De Hert M. Medication adherence in schizophrenia: factors influencing adherence and consequences of nonadherence, a systematic literature review. Ther Adv Psychopharmacol. 2013;3(4):200–18.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Tessier A, Boyer L, Husky M, Bayle F, Llorca PM, Misdrahi D. Medication adherence in schizophrenia: The role of insight, therapeutic alliance and perceived trauma associated with psychiatric care. Psychiatry Res. 2017;257:315–21.

    Article  PubMed  Google Scholar 

  23. Novick D, Montgomery W, Treuer T, Aguado J, Kraemer S, Haro JM. Relationship of insight with medication adherence and the impact on outcomes in patients with schizophrenia and bipolar disorder: results from a 1-year European outpatient observational study. BMC Psychiatry. 2015;15:189.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Noordraven EL, Wierdsma AI, Blanken P, Bloemendaal AF, Mulder CL. Depot-medication compliance for patients with psychotic disorders: the importance of illness insight and treatment motivation. Neuropsychiatr Dis Treat. 2016;12:269–74.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Chai X, Liu Y, Mao Z, Li S. Barriers to medication adherence for rural patients with mental disorders in eastern China: a qualitative study. BMC Psychiatry. 2021;21(1):141.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Kikkert MJ, Schene AH, Koeter MW, Robson D, Born A, Helm H, et al. Medication adherence in schizophrenia: exploring patients’, carers’ and professionals’ views. Schizophr Bull. 2006;32(4):786–94.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Charlson FJ, Baxter AJ, Cheng HG, Shidhaye R, Whiteford HA. The burden of mental, neurological, and substance use disorders in China and India: a systematic analysis of community representative epidemiological studies. Lancet. 2016;388(10042):376–89.

    Article  PubMed  Google Scholar 

  28. Huang Y, Wang Y, Wang H, Liu Z, Yu X, Yan J, et al. Prevalence of mental disorders in China: a cross-sectional epidemiological study. Lancet Psychiatry. 2019;6(3):211–24.

    Article  PubMed  Google Scholar 

  29. Qi H, Zong QQ, An FR, Zhang L, Ungvari GS, Sim K, et al. Treatment rate of schizophrenia in China: a meta-analysis of epidemiological studies. Psychiatr Q. 2020;91(3):863-875.

  30. Thiel C, Richter C, Samos FZ, Heise M, Frese T, Fankhaenel T. Pushing occupational rehabilitation - implementation of a therapy diary in the outpatient aftercare of psychosomatic rehabilitation may promote the occupational reintegration process: a survey of therapists and patients. J Occup Med Toxicol. 2021;16(1):15.

    Article  PubMed  PubMed Central  Google Scholar 

  31. Palinkas LA, Horwitz SM, Green CA, Wisdom JP, Duan N, Hoagwood K. Purposeful sampling for qualitative data collection and analysis in mixed method implementation research. Admin Pol Ment Health. 2015;42(5):533–44.

    Article  Google Scholar 

  32. Francis JJ, Johnston M, Robertson C, Glidewell L, Entwistle V, Eccles MP, et al. What is an adequate sample size? Operationalising data saturation for theory-based interview studies. Psychol Health. 2010;25(10):1229–45.

    Article  PubMed  Google Scholar 

  33. Bowen G. Naturalisti inquiry and the saturation concept: a research note. Qual Res. 2008;8(1):137–52.

    Article  Google Scholar 

  34. John Geddes JP, McKnight R. Psychiatry. 4th ed. New York: Oxford University Press Inc.; 2012.

    Google Scholar 

  35. Liu J, Ma H, He YL, Xie B, Xu YF, Tang HY, et al. Mental health system in China: history, recent service reform and future challenges. World Psychiatry. 2011;10(3):210–6.

    Article  PubMed  PubMed Central  Google Scholar 

  36. Xiang YT, Ng CH, Yu X, Wang G. Rethinking progress and challenges of mental health care in China. World Psychiatry. 2018;17(2):231–2.

    Article  PubMed  PubMed Central  Google Scholar 

  37. Rong Li HA. Cai Li, Situ Meling: Qualitative research on medication complicance of patients with schizophrenia. Chinese Gen Pract Nurs. 2013;11(11):2977–9.

    Google Scholar 

  38. Yang Qionghua XY, Zheng K, Yalan L. Effect of knowledge and behavioral level of caregivers on medication compliance in patients with severe mental disorders. J Guangdong Med Univ. 2018;36(5):581-584.

  39. Horne R, Graupner L, Frost S, Weinman J, Wright SM, Hankins M. Medicine in a multi-cultural society: the effect of cultural background on beliefs about medications. Soc Sci Med. 2004;59(6):1307–13.

    Article  PubMed  Google Scholar 

  40. Yongying L. The psychology and nursing of the mental inpatients that refuse to take medicine. Mod Prev Med. 2007;34(7):1335-1336.

  41. Li SX, Phillips MR. Witch doctors and mental illness in mainland China: a preliminary study. Am J Psychiatry. 1990;147(2):221–4.

    Article  CAS  PubMed  Google Scholar 

  42. Gault I, Gallagher A, Chambers M. Perspectives on medicine adherence in service users and carers with experience of legally sanctioned detention and medication: a qualitative study. Patient Prefer Adherence. 2013;7:787–99.

    Article  PubMed  PubMed Central  Google Scholar 

  43. Dibonaventura M, Gabriel S, Dupclay L, Gupta S, Kim E. A patient perspective of the impact of medication side effects on adherence: results of a cross-sectional nationwide survey of patients with schizophrenia. BMC Psychiatry. 2012;12:20.

    Article  PubMed  PubMed Central  Google Scholar 

  44. Corrigan PW, Watson AC, Miller FE. Blame, shame, and contamination: the impact of mental illness and drug dependence stigma on family members. J Fam Psychol. 2006;20(2):239–46.

    Article  PubMed  Google Scholar 

  45. Phillips MR, Pearson V, Li F, Xu M, Yang L. Stigma and expressed emotion: a study of people with schizophrenia and their family members in China. Br J Psychiatry. 2002;181:488–93.

    Article  PubMed  Google Scholar 

  46. Saxena S, Thornicroft G, Knapp M, Whiteford H. Resources for mental health: scarcity, inequity, and inefficiency. Lancet. 2007;370(9590):878–89.

    Article  PubMed  Google Scholar 

  47. Chien WT, Yeung FK, Chan AH. Perceived stigma of patients with severe mental illness in Hong Kong: relationships with patients' psychosocial conditions and attitudes of family caregivers and health professionals. Admin Pol Ment Health. 2014;41(2):237–51.

    Article  Google Scholar 

  48. Misdrahi D, Petit M, Blanc O, Bayle F, Llorca PM. The influence of therapeutic alliance and insight on medication adherence in schizophrenia. Nord J Psychiatry. 2012;66(1):49–54.

    Article  PubMed  Google Scholar 

  49. Roche E, Madigan K, Lyne JP, Feeney L, O'Donoghue B. The therapeutic relationship after psychiatric admission. J Nerv Ment Dis. 2014;202(3):186–92.

    Article  PubMed  Google Scholar 

  50. Li L, Deng M, Liu Z, Rohrbaugh R. A qualitative study of implementation challenges of mental health clubhouse rehabilitation services in China's Hunan Province. Psychiatr Serv. 2019;70(8):674–80.

    Article  PubMed  Google Scholar 

  51. Scott J, Colom F, Pope M, Reinares M, Vieta E. The prognostic role of perceived criticism, medication adherence and family knowledge in bipolar disorders. J Affect Disord. 2012;142(1-3):72–6.

    Article  PubMed  Google Scholar 

  52. Cetin N, Aylaz R. The effect of mindfulness-based psychoeducation on insight and medication adherence of schizophrenia patients. Arch Psychiatr Nurs. 2018;32(5):737–44.

    Article  PubMed  Google Scholar 

  53. Zygmunt A, Olfson M, Boyer CA, Mechanic D. Interventions to improve medication adherence in schizophrenia. Am J Psychiatry. 2002;159(10):1653–64.

    Article  PubMed  Google Scholar 

  54. Giron M, Fernandez-Yanez A, Mana-Alvarenga S, Molina-Habas A, Nolasco A, Gomez-Beneyto M. Efficacy and effectiveness of individual family intervention on social and clinical functioning and family burden in severe schizophrenia: a 2-year randomized controlled study. Psychol Med. 2010;40(1):73–84.

    Article  CAS  PubMed  Google Scholar 

  55. Liu Shiyan LX, Wei Z, Ye Z, Xiaoqian M, Sha R, Shuqiao Y, et al. The Care Experience and Burden among Families of Chronic Schizophrenics: A Qualitative Study. Chinese J Clin Psychol. 2015;23(2):262-267.

  56. Xiong W, Phillips MR, Hu X, Wang R, Dai Q, Kleinman J, et al. Family-based intervention for schizophrenic patients in China. A randomised controlled trial. Br J Psychiatry. 1994;165(2):239–47.

    Article  CAS  PubMed  Google Scholar 

  57. Ma H. Integration of hospital and community services - the ‘686 Project’ - is a crucial component in the reform of China’s mental health services. Shanghai Arch Psychiatry. 2012;24(3):172-174.

  58. Good BJ, Good MJ. Significance of the 686 program for China and for global mental health. Shanghai Arch Psychiatry. 2012;24(3):175–7.

    PubMed  PubMed Central  Google Scholar 

  59. Ran MS, Chui CH, Wong IY, Mao WJ, Lin FR, Liu B, et al. Family caregivers and outcome of people with schizophrenia in rural China: 14-year follow-up study. Soc Psychiatry Psychiatr Epidemiol. 2016;51(4):513–20.

    Article  PubMed  Google Scholar 

  60. Li QHX, Wen H, et al. Retrospective analysis of treatment effectiveness among patients in Mianyang Municipality enrolled in the national community management program for schizophrenia. Shanghai Jingshen Yixue. 2012;24:131–9.

    Google Scholar 

  61. Raeburn T, Schmied V, Hungerford C, Cleary M. Self-determination theory: a framework for clubhouse psychosocial rehabilitation research. Issues Ment Health Nurs. 2015;36(2):145–51.

    Article  PubMed  Google Scholar 

  62. Xu DR, Xiao S, He H, Caine ED, Gloyd S, Simoni J, et al. Lay health supporters aided by mobile text messaging to improve adherence, symptoms, and functioning among people with schizophrenia in a resource-poor community in rural China (LEAN): A randomized controlled trial. PLoS Med. 2019;16(4):e1002785.

    Article  PubMed  Google Scholar 

  63. Zhou Y, Rosenheck RA, He H. Health insurance in China: variation in co-payments and psychiatric hospital utilization. J Ment Health Policy Econ. 2014;17(1):25–32.

    PubMed  Google Scholar 

  64. Organization GWH. Mental health atlas 2014; 2015.

    Google Scholar 

  65. Qureshi O, Endale T, Ryan G, Miguel-Esponda G, Iyer SN, Eaton J, et al. Barriers and drivers to service delivery in global mental health projects. Int J Ment Heal Syst. 2021;15(1):14.

    Article  Google Scholar 

  66. Song Yan LY, Yao Juqin, Liu Dan, Chen Jia, He Guoping: Application of 'clubhouse model' in community mental illness rehabilitation. China J Mod Med 2014, 24(14).

  67. Jing L, Chang WC, Rohrbaugh R, Ouyang X, Chen E, Liu Z, et al. The psychiatry major: a curricular innovation to improve undergraduate psychiatry education in China. Acad Psychiatry. 2018;42(3):376–81.

    Article  PubMed  Google Scholar 

  68. Hu X, Rohrbaugh R, Deng Q, He Q, Munger KF, Liu Z. Expanding the Mental Health Workforce in China: narrowing the mental health service gap. Psychiatr Serv. 2017;68(10):987–9.

    Article  PubMed  Google Scholar 

  69. Zhou W, Yu Y, Zhao X, Xiao S, Chen L. Evaluating China’s mental health policy on local-level promotion and implementation: a case study of Liuyang Municipality. BMC Public Health. 2019;19(1):24.

    Article  PubMed  PubMed Central  Google Scholar 

  70. Xiang Y, Li L, Ungvari GS, Chiu HF. The proposed national mental health law in China: a landmark document for the protection of psychiatric patients’ civil rights. Shanghai Arch Psychiatry. 2012;24(1):48–9.

    PubMed  PubMed Central  Google Scholar 

  71. Xiong W, Phillips MR. Translated and annotated version of the 2015-2020 National Mental Health Work Plan of the People’s Republic of China. Shanghai Arch Psychiatry. 2016;28(1):4–17.

    PubMed  PubMed Central  Google Scholar 

  72. Collins PY, Patel V, Joestl SS, March D, Insel TR, Daar AS, et al. Grand challenges in global mental health. Nature. 2011;475(7354):27–30.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  73. Thornicroft G, Tansella M. Components of a modern mental health service: a pragmatic balance of community and hospital care: overview of systematic evidence. Br J Psychiatry. 2004;185:283–90.

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

We would like to thank all the mental health professionals who participated in the study. We would also like to thank Xinran Hu and Wen Zhang for their support and help with recruitment.

Funding

This study was funded by the Hunan Provincial Innovation Foundation for Post-graduate (CX20190087) and the National Natural Science Foundation of China (81801353 and 82071506). The funding institution played no part in the design and conduction of the study and did not influence the analysis and interpretation of the data or writing of the manuscript.

Author information

Authors and Affiliations

  1. National Clinical Research Center for Mental Disorders, and Department of Psychiatry, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China

    Mengjie Deng, Xuan Ouyang & Zhening Liu

  2. Faculty of Medicine, McGill University, Montreal, QC, Canada

    Shuyi Zhai & Brendan Ross

Authors
  1. Mengjie Deng
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Shuyi Zhai
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Xuan Ouyang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Zhening Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Brendan Ross
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

ZL supervised the study. MD and XO designed the study, conducted the interviews and analyzed the data. MD drafted the manuscript. BR, SZ and XO reviewed the manuscript several times and provided critical revisions. All the authors participated in the generation of the themes and contributed to the interpretation of results. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Xuan Ouyang.

Ethics declarations

Ethics approval and consent to participate

All of the participants signed informed consent before the interview. The study was approved by the ethics committee of the Second Xiangya Hospital of Central South University (2016/036) in accordance with the Declaration of Helsinki.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Deng, M., Zhai, S., Ouyang, X. et al. Factors influencing medication adherence among patients with severe mental disorders from the perspective of mental health professionals. BMC Psychiatry 22, 22 (2022). https://doi.org/10.1186/s12888-021-03681-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12888-021-03681-6

Keywords

BMC Psychiatry

ISSN: 1471-244X

Contact us